Palatin Technologies, Inc. Common Stock (PTN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Palatin Technologies, Inc. Common Stock (PTN) has a cash flow conversion efficiency ratio of -0.417x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.42 Million) by net assets ($10.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Palatin Technologies, Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.
Palatin Technologies, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how Palatin Technologies, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check PTN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Palatin Technologies, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Palatin Technologies, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kingsmen C.M.T.I. Public Company Limited
BK:K
|
0.102x |
|
Air Industries Group
NYSE MKT:AIRI
|
0.000x |
|
Delorean Corporation Ltd
AU:DEL
|
-0.423x |
|
Neuroone Medical Technologies Corp
NASDAQ:NMTC
|
-0.247x |
|
Leyand International Tbk
JK:LAPD
|
0.140x |
|
Genomtec S.A.
WAR:GMT
|
-0.262x |
|
Botala Energy Ltd
AU:BTE
|
-0.032x |
|
4Imprint Group Plc
LSE:FOUR
|
0.566x |
Annual Cash Flow Conversion Efficiency for Palatin Technologies, Inc. Common Stock (1996–2025)
The table below shows the annual cash flow conversion efficiency of Palatin Technologies, Inc. Common Stock from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Palatin Technologies, Inc. Common Stock.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $-4.78 Million | $-21.31 Million | 4.460x | -98.42% |
| 2024-06-30 | $-111.50K | $-31.46 Million | 282.173x | +1865.82% |
| 2023-06-30 | $-1.98 Million | $-28.42 Million | 14.354x | +880.37% |
| 2022-06-30 | $16.27 Million | $-29.92 Million | -1.839x | -303.25% |
| 2021-06-30 | $49.65 Million | $-22.65 Million | -0.456x | -188.49% |
| 2020-06-30 | $80.17 Million | $41.33 Million | 0.515x | +337.94% |
| 2019-06-30 | $100.55 Million | $-21.78 Million | -0.217x | -443.00% |
| 2018-06-30 | $26.96 Million | $1.70 Million | 0.063x | +102.53% |
| 2017-06-30 | $-5.16 Million | $12.88 Million | -2.494x | -192.61% |
| 2016-06-30 | $-17.59 Million | $-47.36 Million | 2.693x | +346.07% |
| 2015-06-30 | $12.20 Million | $-13.36 Million | -1.095x | +12.23% |
| 2014-06-30 | $9.79 Million | $-12.21 Million | -1.247x | -109.95% |
| 2013-06-30 | $22.98 Million | $-13.65 Million | -0.594x | +92.98% |
| 2012-06-30 | $1.83 Million | $-15.49 Million | -8.459x | -1295.05% |
| 2011-06-30 | $18.19 Million | $-11.03 Million | -0.606x | +1.39% |
| 2010-06-30 | $9.32 Million | $-5.73 Million | -0.615x | +62.57% |
| 2009-06-30 | $3.31 Million | $-5.44 Million | -1.643x | +47.69% |
| 2008-06-30 | $6.55 Million | $-20.58 Million | -3.141x | -163.94% |
| 2007-06-30 | $18.53 Million | $-22.05 Million | -1.190x | +7.13% |
| 2006-06-30 | $18.30 Million | $-23.45 Million | -1.281x | -133.44% |
| 2005-06-30 | $9.23 Million | $-5.06 Million | -0.549x | +55.18% |
| 2004-06-30 | $19.39 Million | $-23.74 Million | -1.225x | -14.86% |
| 2003-06-30 | $18.66 Million | $-19.89 Million | -1.066x | +29.55% |
| 2002-06-30 | $8.69 Million | $-13.15 Million | -1.513x | -114.75% |
| 2001-06-30 | $11.92 Million | $-8.40 Million | -0.705x | +43.02% |
| 2000-06-30 | $6.91 Million | $-8.54 Million | -1.237x | +96.43% |
| 1999-06-30 | $300.00K | $-10.40 Million | -34.667x | -1492.79% |
| 1998-06-30 | $3.40 Million | $-7.40 Million | -2.176x | -420.23% |
| 1997-06-30 | $9.80 Million | $-4.10 Million | -0.418x | +56.18% |
| 1996-06-30 | $2.84 Million | $-2.71 Million | -0.955x | -- |
About Palatin Technologies, Inc. Common Stock
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, … Read more